What is supplement substantiation?

Substantiation is the process of gathering and documenting scientific evidence that supports the health claims you make on your supplement labels and marketing materials. The FDA requires that all structure–function claims be truthful, non-misleading, and substantiated by competent and reliable scientific evidence — typically clinical trials on healthy human subjects.

How does Nutra Comp's AI analysis work?

Nutra Comp searches PubMed for clinical trials relevant to your ingredient, filters for studies on healthy human subjects with oral administration, and uses AI to extract key data: p-values, effect sizes, study design, population details, and conclusions. It distinguishes between across-group and within-group significance and ranks evidence strength with a confidence scoring system.

What data sources does Nutra Comp use?

Nutra Comp primarily searches PubMed/MEDLINE, the world's largest biomedical literature database maintained by the U.S. National Library of Medicine. We focus on peer-reviewed clinical trials, randomised controlled trials (RCTs), meta-analyses, and systematic reviews.

Are the generated claims FDA-compliant?

Yes. Nutra Comp generates structure–function claims in strict accordance with the FDA Small Entity Compliance Guide. All claims avoid explicit and implicit disease references. However, we recommend having your legal/regulatory team review the final output before use, as Nutra Comp is a tool to assist — not replace — professional compliance review.

How long does a typical ingredient search take?

Most ingredient searches complete within 5–15 minutes, depending on the volume of clinical literature available. Compare this to the typical manual process which can take 40–100+ hours per ingredient when done by a human compliance expert.

Can I export my reports?

Absolutely. All clinical evidence reports, structure–function claims, and substantiation memos can be exported as professional PDF documents. These are formatted for easy sharing with your legal team, regulatory reviewers, or business partners.

What does 'ingredient searches per month' mean?

Each search is one ingredient analysis — for example, searching 'Ashwagandha' or 'Vitamin D3'. The search generates a complete evidence report, claims, and substantiation memo for that ingredient. Your monthly allowance resets on your billing date.

When will Nutra Comp be available?

We're currently in private beta. Join the waitlist to get early access and be notified when we launch. Early waitlist members will receive priority access and special launch pricing.

Boswellia: Clinical Evidence & Substantiation Summary

Clinical Trials

Strongest Evidence

Joint Health

Typical Dosage

100–500 mg/day (standardised to AKBA)

Common Forms

Boswellia serrata extract (65% boswellic acids)

What Is Boswellia?

Boswellia serrata (Indian frankincense) resin extract contains boswellic acids that have potent anti-inflammatory effects through a unique mechanism — 5-LOX inhibition — distinct from NSAIDs. Clinical evidence strongly supports its use for joint and inflammatory conditions.

Mechanism of action: Boswellic acids, particularly AKBA (acetyl-11-keto-β-boswellic acid), selectively inhibit 5-lipoxygenase (5-LOX), blocking leukotriene synthesis. Unlike NSAIDs, this mechanism avoids COX-mediated GI side effects. Boswellic acids also inhibit human leukocyte elastase and matrix metalloproteinases.

Clinical Evidence Summary

Below are 5 key clinical studies on Boswellia. Nutra Comp analyses 27+ studies in its full clinical evidence report.

Systematic review and meta-analysis2018PMID: 30411529

Boswellia serrata for osteoarthritis: systematic review

Population: 7 RCTs, 545 patients

Key finding: Boswellia extract significantly improved pain and function scores in knee OA (SMD -0.58, p<0.001) vs. placebo.

Meta-analysis2019PMID: 31249528

Boswellia and inflammatory markers

Population: 5 RCTs

Key finding: Boswellia supplementation significantly reduced CRP and matrix metalloproteinase levels (p<0.01).

Systematic review2015PMID: 25688926

Boswellia for inflammatory bowel conditions

Population: 4 RCTs

Key finding: Boswellia serrata showed comparable efficacy to mesalamine for maintaining remission in ulcerative colitis.

RCT, double-blind2017PMID: 29065496

Rapid-onset effects of AprèsFlex boswellia

Population: 60 adults with knee OA

Key finding: AprèsFlex® (100 mg/day) significantly improved pain and function scores within 5 days (p<0.01) and continued improving over 30 days.

RCT2021PMID: 32540634

Boswellia and respiratory health

Population: 40 asthmatic patients

Key finding: Boswellia extract (300 mg TID for 6 weeks) significantly improved lung function parameters and reduced rescue inhaler use.

Evidence-Based Structure–Function Claims

Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.

“Supports joint comfort and mobility”

Category: Joint Health · Confidence: 9/10

“Supports a healthy inflammatory response via 5-LOX modulation”

Category: Inflammation · Confidence: 8/10

“Supports healthy connective tissue”

Category: Joint Health · Confidence: 7/10

Get the full substantiation report for Boswellia

Includes all 27+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.

Join Waitlist for Full Access

Related Ingredients

Omega-3 Fatty Acids

214 studies · Cardiovascular Health

Curcumin

78 studies · Inflammatory Response

Ginger

78 studies · Digestive Health

Key Terms

Randomised Controlled Trial (RCT)Standardised Extract Clinically Effective Dose

Frequently Asked Questions

Is Boswellia FDA approved?

Boswellia is sold as a dietary supplement under DSHEA. Several branded extracts (5-Loxin, AprèsFlex) have self-affirmed GRAS status.

What are the most studied benefits?

Joint comfort and mobility (particularly knee OA), anti-inflammatory response via unique 5-LOX pathway, and emerging evidence for respiratory and GI health.

What dosage is used?

Standardised extracts: 100–250 mg/day of AKBA-enriched forms (AprèsFlex, 5-Loxin). Traditional extracts: 300–500 mg TID of 65% boswellic acid preparations.

Stop Spending Weeks on Substantiation

Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.

Join the Waitlist